Bryan Garnier & Co Initiates the Coverage of Aelis Farma With a “Buy” Recommendation

Bryan Garnier & Co Initiates the Coverage of Aelis Farma With a “Buy” Recommendation
CANNANNEW REPORT

BORDEAUX, France–(BUSINESS WIRE)–Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 – ticker: AELIS) (Paris:AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the « Company »), announces today the publication of an initiation report by Bryan Garnier & Co, a pan-European investment bank focusing on growth companies. In the initiation report entitled “Aelis in Wonderland”, published on March 29, 2022, Bryan Garnier & Co initiates the coverage of the stock with a buy recommendation and values the company at 21 euros per share. *** Next financial publication: 2021 Annual Results: April 4, 2022 (before market) About Bryan Garnier & Co Bryan, Garnier & Co is a European, full-service growth-focused independent investment banking founded in 1996. The firm provides equity research, sales and trading, private and public capital raising as well as M&A services to growth companies and their investors. It focuses on key growth sectors of the economy including Technology, Healthcare, Consumer and Business Services. Bryan, Garnier & Co is a fully registered broker dealer authorized and regulated by the FCA in Europe and the FINRA in the U.S. Bryan, Garnier & Co is headquartered in London, with additional offices in Paris, Munich, Stockholm, Oslo and Reykjavik as well as New York and Palo Alto. The firm is a member of the London Stock Exchange. For more information: http://www.bryangarnier.com About AELIS FARMA Founded in 2013, Aelis Farma is a biopharmaceutical company that is developing a new class of drugs, the Signaling Specific inhibitors of the CB1 receptor of the endocannabinoid system (CB1-SSi). These new molecules hold great potential in the treatment of many brain diseases. CB1-SSi were developed by Aelis Farma on the basis of the discovery of a new natural defense mechanism of the brain made by the team of Dr. Pier Vincenzo Piazza, CEO…

Excerpt only …
READ MORE BELOW
Source : Bryan Garnier & Co Initiates the Coverage of Aelis Farma With a “Buy” Recommendation

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.